Symbols

Symbols

TRML

TRML

Tourmaline Bio Drops from S&P Global BMI Index: A Biotech Company Focused on Immune and Inflammatory Diseases

Novartis completes acquisition of Tourmaline Bio, deepens cardiovascular innovation.

Novartis closes purchase of Tourmaline Bio

Novartis Completes Acquisition of Tourmaline Bio with 92.94% Stake Acquisition

Thursday Oct 09, 2025

Investor Rights Law Firm Investigates Tourmaline Bio, CoreCard, PB Bankshares Mergers

Tuesday Oct 07, 2025

Halper Sadeh Investigates First Savings, Aris Water, and Tourmaline Bio Shareholders

Monday Sep 29, 2025

Novartis Launches Tender Offer to Acquire Tourmaline Bio

Novartis Commences Tender Offer to Acquire Tourmaline Bio for $48 Per Share

Novartis offers to buy Tourmaline Bio at $48/shr in cash

Friday Sep 26, 2025

Tourmaline Bio: MACD Death Cross and Bearish Marubozu Triggered on 15-Minute Chart

Tourmaline Bio's 15-min chart shows KDJ Death Cross, Bearish Marubozu formation.

Tourmaline Bio's 15min chart triggers KDJ Golden Cross, bullish Marubozu formation

Thursday Sep 25, 2025

Tourmaline Bio's 15min chart triggered KDJ Death Cross, Bearish Marubozu

Tourmaline Bio's 15min chart shows MACD and KDJ death crosses.

Tuesday Sep 23, 2025

Tourmaline Bio: MACD Death Cross, Bearish Marubozu Triggered on 15-Minute Chart.

Tourmaline Bio's 15min Chart Shows RSI Overbought, KDJ Death Cross

Monday Sep 22, 2025

Tourmaline Bio's 15-min chart shows MACD Death Cross and KDJ Death Cross

Brodsky & Smith investigates PROS Holdings, Tourmaline Bio acquisitions.

Friday Sep 19, 2025

Tourmaline Bio's 15min chart triggered MACD Death Cross, Bollinger Bands Narrowing, KDJ Death Cross

Tourmaline Bio's 15min chart shows KDJ Golden Cross, Bullish Marubozu signal.